FdaApplication
ANDA 211264
Identifiers
- fda_app_no: ANDA211264
Properties
| Property | Value |
|---|---|
| applicant_name | UBI PHARMA INC |
| application_type | ANDA |
| approval_date | 2023-03-09 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VORICONAZOLE | VORICONAZOLE | 200MG/VIAL | POWDER;INTRAVENOUS |
1 product